Contracts › W81XWH20C0030
W81XWH20C0030: Cryopreserved Platelet (CPP) Development for Us Fda Licensure
Awarded to Cellphire, Inc. by Defense Health Agency.
$70.3Mobligated
$73.6Mpotential value
31 October 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | W81XWH20C0030 |
|---|---|
| Awardee | Cellphire, Inc. |
| Awarding agency | Defense Health Agency |
| Awarding office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN94 R&D- Medical: Other (Engineering Development) |
| Place of performance | MD |
| Offers received | 3 |
| Period of performance | 20 December 2019 to 31 October 2028 |
| Potential end | 31 October 2028 |
| Estimated recompete solicitation | ~Q2 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record